Thiocyanate reduces motor impairment in the hmpo-a53t pd mouse model while reducing mpo-oxidation of alpha synuclein in enlarged lyve1/aqp4 positive periventricular glymphatic vessels

HIGHLIGHTS

• who: Wanda F. Reynolds et al. from the Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA Gottfried Schatz Research Center, Division of Molecular Biology and Biochemistry, Medical University of Graz have published the Article: Thiocyanate Reduces Motor Impairment in the hMPO-A53T PD Mouse Model While Reducing MPO-Oxidation of Alpha Synuclein in Enlarged LYVE1/AQP4 Positive Periventricular Glymphatic Vessels, in the Journal: Antioxidants 2022, 2342 of /2022/
• what: In this study the hMPO-A53T mice were treated with (SCN- ) which is a favored substrate of MPO as compared to chlorine. The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.